{
    "address": "Medicon Village, Scheelevagen 2",
    "city": "Lund",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W3928F229",
    "description": "Genovis AB engages in the research and development of enzyme products. The company is headquartered in Lund, Skane and currently employs 35 full-time employees. The company went IPO on 2005-11-11. The firm offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer, inflammatory and autoimmune diseases. The portfolio comprises FabRICATOR, a genetically modified enzyme the cleaves antibodies in two parts, and IgGZERO, a protein that specifically cleaves the sugar molecules that occur naturally on antibodies. The products within the nano portfolio are primarily directed at the preclinical market. The firm markets and sells its products through dealers and distributors in the European, North American and Asian continents. As of December 31, 2011, it operated a wholly owned subsidiary, Eijdo Research AB.",
    "employeeTotal": "35.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Life Sciences Tools & Services",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Life Sciences Tools & Services",
    "gsector": "Health Care",
    "gsubind": "Life Sciences Tools & Services",
    "ipo": "2005-11-11",
    "isin": "SE0002485979",
    "logo": "https://finnhub.io/api/logo?symbol=GENO.ST",
    "marketCapitalization": 3139.081,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "Genovis AB",
    "phone": "4646101230.0",
    "sedol": "B0PCQR9",
    "shareOutstanding": 66.261714,
    "state": "SKANE",
    "ticker": "GENO.ST",
    "weburl": "https://www.genovis.com/"
}